Zuraw Qing Che 4
4 · Vor Biopharma Inc. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Zuraw Qing Che
Chief Development Officer
Transactions
- Award
Common Stock
2025-07-17+937,080→ 937,080 total - Award
Employee Stock Option (right to buy)
2025-07-17+4,373,040→ 4,373,040 totalExercise: $2.38Exp: 2035-07-16→ Common Stock (4,373,040 underlying)
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on August 1, 2026, with the remainder vesting in substantially equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.
- [F2]1/4th of the shares underlying the option vest on July 17, 2026, with the remainder vesting in substantially equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.